Overview of India’s Pharmaceutical Export Market
The Indian pharma company is known as the global leader in the export of generic medicines at a much lower cost. If we determine by size, then India’s pharmaceutical industry is the third largest by volume.
The export value in 2023-2024 was worth about $27.9 billion, with the top export destinations like- US, UK, South Africa, the Netherlands, and even France.
India has more than 10,500 manufacturing facilities and even has the highest number of US-FDA-compliant pharma plants. In short, the Indian pharma industry is known for its high-quality medicines and affordability.
India’s Pharmaceutical Export Landscape
India has been known to be the global leader in the pharmaceutical industry. In India, you can find a wide range of medicines and products that can support one’s health at affordable prices.
India is the global supplier of generic medicines at affordable prices.
The Indian pharma company is known as the global leader in the export of generic medicines at a much lower cost. If we determine by size, then India’s pharmaceutical industry is the third largest by volume.
In short, the Indian pharma industry is known for its high-quality medicines and affordability.
Importance of the Asian Market:
The Asian market has become very important in the global economy. This means offering a significant number of opportunities for businesses worldwide. Many Asian economies have experienced rapid economic growth over the past few decades.
China and India are also driving demand for a wide range of products. However, the Asia market is important because of number of factors like-
We have found that Asia is the home to more than half of the world’s consumer and the middle class is growing.
There is no doubt that Asia has experienced the tremendous economic growth and is one of the fastest growing economies too.
Asia is also the home to many innovation and advanced technologies like artificial intelligence, robotics, and e-commerce.
The manufacturing and trade of Asia has contributed 42% of the world’s GDP. Moreover, the fintech sector is expected to reach around $1.5 trillion in annual revenue by 2030.
Key Medicines Exported to Asia
There is different key medicines exported to Asia, and those are:
Generic medicines are cost-effective compared to branded medicines. This ensures the accessibility of medicines for different healthcare needs.
Different conditions like polio, hepatitis, and COVID-19 exist in developing countries. Some of the necessary vaccines are available to help control:
Antiretroviral drugs are another key medicine that is helpful for:
The treatment of HIV or AIDS and Anticancer can help patients regain their health. Over-the-counter medicine includes pain relievers, antipyretics, and health supplements to combat day-to-day difficulties.
India is the world’s largest producer of generic medicine by volume and this counts for 20% of the total global pharmaceutical export. If we talk about the export value then, in in 2023-24 were valued at US\$27.9 billion.
Major Export Destinations in Asia
The Major Export Destinations in Asia are:
China focuses primarily on APIs and specialty medicines. The high demand for both generic and patented drugs has led people to consider Japan. Countries like Indonesia, Thailand, and Vietnam also import medicines and follow all guidelines. Middle Eastern countries are also the top exporters of Indian drugs and formulations.
Competitive Advantages of India’s Pharmaceutical Industry
The Indian pharma companies have several competitive advantages:
Indian companies heavily invest in research and development to introduce new drugs or to improve the existing one’s as well.
India has a skilled workforce- scientists, researchers, and technicians and all of these are well-versed in their work of manufacturing.
India is known for producing high-quality medicines and by being maintaining the pricing.
Accordingly, India exports to more than 200 countries like US, UK, South Africa, Russia, Nepal, and Bangladesh
Regulatory Framework and Compliance
Indian pharmaceutical companies are regulated by several agencies and laws.
Central Drug Standard Control Organization:- They ensure drugs, cosmetics, and diagnostics are safe, effective, and high-quality.
National Pharmaceutical Pricing Authority:- They are responsible for fixing the prices of bulk medicines.
The Department of Chemicals and Petrochemicals:- They are responsible for the planning aspects of the pharmaceutical industry.
Contribution to Public Health in Asia
India is known to supply drugs that can help to safeguard individuals’ health. There are different health issues that can be treated, such as:
malaria, tuberculosis, and providing affordable medicine. India is the largest world supplier of medicines, mainly generics, accounting for 40% of the US’s demand.
India’s pharmaceutical industry plays a pivotal role in improving public health in Asia by providing affordable, high-quality medicines and fostering healthcare accessibility-
Steps for Applying to Export Medicines from India
Obtaining a drug manufacturing license is one of the first steps that has to be followed when exporting medicines from India. It is also advisable to register products with the importing country.
Role of Government and Trade Agreements
The Pharmaceutical Export Promotion Council supports exporters with complete guidance. This is done by the Indian Council on the market and policies to deal with the country. The trade agreement is also followed, and this is by being a partner with-
It has been found that ASEAN and even other countries are primarily working to reduce trade barriers through agreements. This means improving cross-border trade and boosting economic cooperation.
The PLI, or production-linked incentive, is a government scheme. It aims to boost domestic manufacturing by giving companies financial incentives. Both schemes aim to cut import reliance by boosting local production. They tie incentives to the rise in the company’s product sales.
Important Documents are Required for Export Purposes from India
Major documents required for export purpose from India are:
This is the government issues license which permits the export of pharmaceutical products.3
A document which mainly verify the product’s quality and also the compliance upon meeting the standard.
This is the unique code which is assigned for the legal import and export of goods.
It is the detailed list of the product with information i.e. the packaging and a commercial invoice for customs and payment purposes.
A form submitted to customs, declaring the contents and value of the exported goods.
The Recipe for India’s Pharmaceutical Export Success
Indian pharmaceutical export business success can be defined by various factors:
India is known for its advanced manufacturing capabilities and at low cost. This is maintained by following complete guidelines such as such as (GMP) Good Manufacturing Practices.
India has a large pool of workforce and all of them contribute towards innovation and ability to produce generic drugs.
Indian pharmaceutical companies have also earned a reputation focusing on both generic and novel formulation drugs.
The Indian government has also implemented policy like-
PLI to easily boost the manufacturing process and even reduce dependency on imports.
Challenges in Exporting Pharmaceuticals to Asia
There is no doubt that there are some guidelines that can hinder the overall export process.
Opportunities for Indian Pharma in Asia
The rising insurance coverage in Asia increases medical accessibility.
The Future of Indian Pharma Exports to Asia
The future of Indian pharma export to Asia looks quite promising and this is mainly impacted by the demand of affordable and high-quality medicines across the region.
With the efficient manufacturing capabilities and cost-efficient production, India is on the top to cater the needsof emerging economies in Asia.
The future of Indian pharmaceutical export to Asia is exponential and is driven by the increasing focus on healthcare access and affordability.
India’s expertise in producing generic drugs, biosimilars, and vaccines at scale aligns perfectly with Asia’s need for cost-effective solutions, especially in countries with developing healthcare systems.
Conclusion
India’s pharma industry has demonstrated its ability to meet Asia’s developing medical care needs.
The Indian pharma sector is ready for sustained growth in the Asian market. India can continue to play a crucial role in enhancing global healthcare accessibility. This is done by overcoming challenges and quickly seizing opportunities.
